Literature DB >> 15311351

Does serum prolactin indicate the presence of seizure in the emergency department patient?

Rade B Vukmir1.   

Abstract

STUDY
OBJECTIVE: We sought to evaluate whether there was a correlation between elevated serum prolactin in patients presenting with the question of seizure.
METHODS: A Convenience sample of 200 consecutive patients were chosen who had a serum prolactin measurement in the setting of seizure activity.
RESULTS: The prolactin level was within a range of 3.90-294.00 mg/dl with an upper limit of normal being 29.9 mg/dl. Patients were ultimately diagnosed with seizure in 54.5% (109 of 200) with an abnormal prolactine in 31.0% (62 of 200). The sensitivity of this serum prolactin was 42%, the specificity was 82%, positive predictive value (PPV) of 74%, and negative predictive value (NPV) of 54%. There was an overall accuracy of 60% in the diagnosis of seizure, with a likelihood ratio of 2.4 (95% Confidence Interval [CI], 1.5-3.9).
CONCLUSION: The measurement of serum prolactin is helpful as a confirmatory test, but not as screening test in the emergency department setting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311351     DOI: 10.1007/s00415-004-0418-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  3 in total

1.  Association of Epileptic and Nonepileptic Seizures and Changes in Circulating Plasma Proteins Linked to Neuroinflammation.

Authors:  John M Gledhill; Elizabeth J Brand; John R Pollard; Richard D St Clair; Todd M Wallach; Peter B Crino
Journal:  Neurology       Date:  2021-01-25       Impact factor: 9.910

2.  Laboratory markers of cardiac and metabolic complications after generalized tonic-clonic seizures.

Authors:  Robert D Nass; Sina Meiling; René P Andrié; Christian E Elger; Rainer Surges
Journal:  BMC Neurol       Date:  2017-09-19       Impact factor: 2.474

3.  Lack of impact of rotavirus vaccines on seizure-related hospitalizations in children under 5 years old in Spain.

Authors:  Alejandro Orrico-Sánchez; Mónica López-Lacort; Cintia Muñoz-Quiles; Javier Díez-Domingo
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.